The SAR 1.6 bln deal gives Fakeeh Care full ownership of Al-Faqih.
Dallah Healthcare Co.completed the sale of its entire 31.21% stake in Al-Faqih Partners to Dr. Soliman Abdel Kader Fakeeh Hospital Co. (Fakeeh Care) on July 20, after all transaction conditions were met, the companies said in separate Tadawul statements. 
Dallah Health said the transaction was completed following the transfer of its shares in Al-Faqih to Fakeeh Care and receipt of the cash consideration.
The company received SAR 466.77 million. Under the transaction agreement announced on May 6, SAR 100 million of the total purchase consideration, of which Dallah Health is entitled to 31.21%, was placed in an escrow account to cover any post-completion claims or liabilities. The amount will remain in escrow for six months, or longer if any dispute arises.
Fakeeh Care said it acquired 100% of Al-Faqih’s share capital for a total cash consideration of about SAR 1.6 billion, including the SAR 100 million held in escrow.
The acquisition makes Al-Faqih a wholly owned subsidiary of Fakeeh Care and adds the group’s second hospital in Riyadh, significantly expanding its presence in the capital.
Fakeeh Care said the deal will diversify its payer mix and patient base by adding self-pay patients and insurance patients covered under Network 6/Class B, complementing its existing focus on higher-tier insurance segments.
Over the medium term, the company expects the integration to generate operational efficiencies, cost savings, and additional revenue growth opportunities across its network.
The acquisition is also expected to increase the group’s consolidated debt due to acquisition financing and the assumption of Al-Faqih’s existing net debt.
The deal will nearly triple Fakeeh Care’s bed capacity in Riyadh by adding Al-Faqih’s 350 operational beds to its existing 185-bed hospital, creating a two-hospital platform with a total capacity of 535 beds.
The SAR 1.6 bln deal gives Fakeeh Care full ownership of Al-Faqih.
Dallah Healthcare Co.completed the sale of its entire 31.21% stake in Al-Faqih Partners to Dr. Soliman Abdel Kader Fakeeh Hospital Co. (Fakeeh Care) on July 20, after all transaction conditions were met, the companies said in separate Tadawul statements.
Dallah Health said the transaction was completed following the transfer of its shares in Al-Faqih to Fakeeh Care and receipt of the cash consideration.
The company received SAR 466.77 million. Under the transaction agreement announced on May 6, SAR 100 million of the total purchase consideration, of which Dallah Health is entitled to 31.21%, was placed in an escrow account to cover any post-completion claims or liabilities. The amount will remain in escrow for six months, or longer if any dispute arises.
Fakeeh Care said it acquired 100% of Al-Faqih’s share capital for a total cash consideration of about SAR 1.6 billion, including the SAR 100 million held in escrow.
The acquisition makes Al-Faqih a wholly owned subsidiary of Fakeeh Care and adds the group’s second hospital in Riyadh, significantly expanding its presence in the capital.
Fakeeh Care said the deal will diversify its payer mix and patient base by adding self-pay patients and insurance patients covered under Network 6/Class B, complementing its existing focus on higher-tier insurance segments.
Over the medium term, the company expects the integration to generate operational efficiencies, cost savings, and additional revenue growth opportunities across its network.
The acquisition is also expected to increase the group’s consolidated debt due to acquisition financing and the assumption of Al-Faqih’s existing net debt.
The deal will nearly triple Fakeeh Care’s bed capacity in Riyadh by adding Al-Faqih’s 350 operational beds to its existing 185-bed hospital, creating a two-hospital platform with a total capacity of 535 beds.
